Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Isolated from 2009 to 2013 in the Republic of Ireland

Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Isolated from 2009 to 2013 in the Republic of Ireland

ABSTRACT Neisseria meningitidis is a common cause of bacterial meningitis in children and young adults worldwide. The 4CMenB vaccine (Bexsero), developed to combat meningococcal serogroup B (MenB) disease, contains subcapsular antigens that may induce immunity against strains of N. meningitidis, reg...

Full description

Bibliographic Details
Main Authors: Robert M. Mulhall, Desiree Bennett, Robert Cunney, Ray Borrow, Jay Lucidarme, Jamie Findlow, Keith A. Jolley, James Bray, Martin C. J. Maiden, Monica Moschioni, Laura Serino, Maria Stella, Duccio Medini
Format: Article
Language:English
Published: American Society for Microbiology 2018-08-01
Series:mSphere
Subjects:
4CMenB
MATS
MenB
NHBA
NadA
Neisseria meningitidis
Online Access:https://journals.asm.org/doi/10.1128/mSphere.00196-18

Internet

https://journals.asm.org/doi/10.1128/mSphere.00196-18

Similar Items